CX3CL1CX3CR1 in Alzheimer’s Disease: A Target for Neuroprotection
Joint Authors
Yin, Min
Chen, Peiqing
Zhao, Wenjuan
Guo, Yanjie
Xu, Juan
Source
Issue
Vol. 2016, Issue 2016 (31 Dec. 2016), pp.1-9, 9 p.
Publisher
Hindawi Publishing Corporation
Publication Date
2016-06-27
Country of Publication
Egypt
No. of Pages
9
Main Subjects
Abstract EN
CX3C chemokine ligand 1 (CX3CL1) is an intriguing chemokine belonging to the CX3C family.
CX3CL1 is secreted by neurons and plays an important role in modulating glial activation in the central nervous system after binding to its sole receptor CX3CR1 which mainly is expressed on microglia.
Emerging data highlights the beneficial potential of CX3CL1-CX3CR1 in the pathogenesis of Alzheimer’s disease (AD), a common progressive neurodegenerative disease, and in the progression of which neuroinflammation plays a vital role.
Even so, the importance of CX3CL1/CX3CR1 in AD is still controversial and needs further clarification.
In this review, we make an attempt to present a concise map of CX3CL1-CX3CR1 associated with AD to find biomarkers for early diagnosis or therapeutic interventions.
American Psychological Association (APA)
Chen, Peiqing& Zhao, Wenjuan& Guo, Yanjie& Xu, Juan& Yin, Min. 2016. CX3CL1CX3CR1 in Alzheimer’s Disease: A Target for Neuroprotection. BioMed Research International،Vol. 2016, no. 2016, pp.1-9.
https://search.emarefa.net/detail/BIM-1098972
Modern Language Association (MLA)
Chen, Peiqing…[et al.]. CX3CL1CX3CR1 in Alzheimer’s Disease: A Target for Neuroprotection. BioMed Research International No. 2016 (2016), pp.1-9.
https://search.emarefa.net/detail/BIM-1098972
American Medical Association (AMA)
Chen, Peiqing& Zhao, Wenjuan& Guo, Yanjie& Xu, Juan& Yin, Min. CX3CL1CX3CR1 in Alzheimer’s Disease: A Target for Neuroprotection. BioMed Research International. 2016. Vol. 2016, no. 2016, pp.1-9.
https://search.emarefa.net/detail/BIM-1098972
Data Type
Journal Articles
Language
English
Notes
Includes bibliographical references
Record ID
BIM-1098972